approved

Приложение 4 на ПЛС от 02.04.2019 г.

Unique identificator:  57272fa0-b7e0-4f77-bab6-c24363376b26

лекарства реимбурсиране

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-04-04 11:17:31
  • Created by: georgi_sivchev
  • Updated at: 2019-04-04 11:17:31
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Fentanyl № II-2555/18.07.2008 Victanyl 100 micrograms/h transdermal patches x 5, Transdermal patch, 100, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Nordic A/S, Denmark 113.79 22.76 136.55 6% 6.83 120.62 24.12 144.74 18% 20.48 141.1 28.22 169.32 КЦ-658/05.03.2009 19.03.2009 19.03.2009 Неактивен 1663
Fentanyl № II-2555/ 18.07.2008 Victanyl 25 micrograms/h transdermal patches x 5, Transdermal patch, 25, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Group PTC ehf, Iceland 13.03 2.61 15.64 6% 0.78 13.81 2.76 16.57 18% 2.35 16.16 3.23 19.39 промяна на обстоятелства НСР-3645/29.05.2014; цената е заличена с решение НСР-6479/18.06.2015 ( в сила от 16.07.2015 ) КЦРР-2430/22.02.2013 11.03.2013 11.03.2013 Заличен 1661
Fentanyl № II-2555/ 18.07.2008 Victanyl 25 micrograms/h transdermal patches x 5, Transdermal patch, 25, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Nordic A/S, Denmark 18.33 3.67 22 6% 1.1 19.43 3.89 23.32 18% 3.3 22.73 4.55 27.28 КЦРР-744/07.06.2012 24.06.2012 24.06.2012 Неактивен 1661
Fentanyl № II-2555/18.07.2008 Victanyl 25 micrograms/h transdermal patches x 5, Transdermal patch, 25, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Nordic A/S, Denmark 35.19 7.04 42.23 6% 2.11 37.3 7.46 44.76 18% 6.33 43.63 8.73 52.36 КЦ-658/05.03.2009 19.03.2009 19.03.2009 Неактивен 1661
Fentanyl № II-2555/ 18.07.2008 Victanyl 50 micrograms/h transdermal patches x 5, Transdermal patch, 50, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Nordic A/S, Denmark 34.81 6.96 41.77 4% 1.39 36.2 7.24 43.44 16% 5.57 41.77 8.35 50.12 КЦРР-744/07.06.2012 24.06.2012 24.06.2012 Неактивен 1662
Fentanyl № II-2555/18.07.2008 Victanyl 50 micrograms/h transdermal patches x 5, Transdermal patch, 50, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Nordic A/S, Denmark 63.53 12.71 76.24 6% 3.81 67.34 13.47 80.81 18% 11.44 78.78 15.76 94.54 КЦ-658/05.03.2009 19.03.2009 19.03.2009 Неактивен 1662
Fentanyl № II-2555/ 18.07.2008 Victanyl 75 micrograms/h transdermal patches x 5, Transdermal patch, 75, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Nordic A/S, Denmark 33.99 6.8 40.79 4% 1.36 35.35 7.07 42.42 16% 5.44 40.79 8.16 48.95 КЦРР-2432/22.02.2013 11.03.2013 11.03.2013 Неактивен 2767
Fentanyl № II-2555/ 18.07.2008 Victanyl 75 micrograms/h transdermal patches x 5, Transdermal patch, 75, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Nordic A/S, Denmark 54.98 11 65.98 4% 2.2 57.18 11.44 68.62 16% 8.8 65.98 13.2 79.18 КЦРР-744/07.06.2012 24.06.2012 24.06.2012 Неактивен 2767
Fentanyl № II-2555/18.07.2008 Victanyl 75 micrograms/h transdermal patches x 5, Transdermal patch, 75, mcg/h, Pack: 5 Actavis Group PTC ehf., Исландия Actavis Nordic A/S, Denmark 92.32 18.46 110.78 6% 5.54 97.86 19.57 117.43 18% 16.62 114.48 22.9 137.38 КЦ-658/05.03.2009 19.03.2009 19.03.2009 Неактивен 2767
Liraglutide EU/1/09/529/003 Victoza, Solution for injection, 6 mg/ ml - 3 ml, mg, Pack: 3 Novo Nordisk A/S, Дания Novo Nordisk a/s Denmark 259.66 51.93 311.59 4% 10 269.66 53.93 323.59 16% 25 294.66 58.93 353.59 НСР-1688/11.11.2013 29.11.2013 29.11.2013 Неактивен 2269
Liraglutide EU/1/09/529/003 Victoza, Solution for injection, 6 mg/ ml - 3 ml, mg, Pack: 3 Novo Nordisk A/S, Дания Novo Nordisk a/s Denmark 260.52 52.1 312.62 4% 10 270.52 54.1 324.62 16% 25 295.52 59.1 354.62 КЦ-2544/09.08.2011 23.08.2011 23.08.2011 Неактивен 2269
Liraglutide EU/1/09/529/003 VICTOZA, Solution for injection, 6 mg/ml - 3 ml, -, Pack: 3 pre-filled pens Novo Nordisk A/S, Дания Novo Nordisk a/s Denmark 242.21 48.44 290.65 4% 9.69 251.9 50.38 302.28 16% 25 276.9 55.38 332.28 НСР-7853/15.01.2016.; НСР-12221/03.04.2017; НСР-17686/09.01.2019 предварително изпълнение 09.01.2019 02.02.2019 Активен 2269
Liraglutide EU/1/09/529/003 VICTOZA, Solution for injection, 6 mg/ml - 3 ml, -, Pack: 3 pre-filled pens Novo Nordisk A/S, Дания Novo Nordisk a/s Denmark 255.57 51.11 306.68 4% 10 265.57 53.11 318.68 16% 25 290.57 58.11 348.68 НСР-7853/15.01.2016.; НСР-12221/03.04.2017 18.04.2017 02.05.2017 Неактивен 2269
Liraglutide EU/1/09/529/003 VICTOZA, Solution for injection, 6 mg/ml - 3 ml, -, Pack: 3 pre-filled pens Novo Nordisk A/S, Дания Novo Nordisk a/s Denmark 259.46 51.89 311.35 4% 10 269.46 53.89 323.35 16% 25 294.46 58.89 353.35 НСР-7853/15.01.2016. 02.02.2016 02.02.2016 Неактивен 2269
Boceprevir EU/1/11/704/001 Victrelis, Capsule, hard, 200, mg, Pack: 336 Merck Sharp & Dohme Ltd., Обединено Кралство S-P Labo NV Industriepark 30 B-2220 Heist-opden-Berg, Белгия 4004.62 800.92 4805.54 4% 10 4014.62 802.92 4817.54 16% 25 4039.62 807.92 4847.54 НСР-8522/16.03.2016; НСР-11738/10.02.2017 31.03.2016 02.03.2017 Заличен 3420
Boceprevir EU/1/11/704/001 Victrelis, Capsule, hard, 200, mg, Pack: 336 Merck Sharp & Dohme Ltd., Обединено Кралство S-P Labo NV Industriepark 30 B-2220 Heist-opden-Berg, Белгия 4004.62 800.92 4805.54 4% 10 4014.62 802.92 4817.54 16% 25 4039.62 807.92 4847.54 НСР-8522/16.03.2016 31.03.2016 31.03.2016 Неактивен 3420
Boceprevir EU/1/11/704/001 Victrelis, Capsule, hard, 200, mg, Pack: 336 Merck Sharp & Dohme Ltd., Обединено Кралство S-P Labo NV Industriepark 30 B-2220 Heist-opden-Berg, Белгия 4004.62 800.92 4805.54 4% 10 4014.62 802.92 4817.54 16% 25 4039.62 807.92 4847.54 НСР-8522/16.03.2016 31.03.2016 31.03.2016 Неактивен 3420
Boceprevir EU/1/11/704/001 Victrelis, Capsule, hard, 200, mg, Pack: 336 Merck Sharp & Dohme Ltd., Обединено Кралство S-P Labo NV Industriepark 30 B-2220 Heist-opden-Berg, Белгия 4831.13 966.23 5797.36 4% 10 4841.13 968.23 5809.36 16% 25 4866.13 973.23 5839.36 Оставена без разглеждане жалба от Комисия по прозрачност КП-115/03.12.2014 НСР-4659/25.09.2014 16.12.2014 16.12.2014 Неактивен 3420
Boceprevir EU/1/11/704/001 Victrelis, Capsule, hard, 200, mg, Pack: 336 Merck Sharp & Dohme Ltd., Обединено Кралство S-P Labo NV Industriepark 30 B-2220 Heist-opden-Berg, Белгия 5577.64 1115.53 6693.17 4% 10 5587.64 1117.53 6705.17 16% 25 5612.64 1122.53 6735.17 НСР-257/25.06.2014 30.07.2013 30.07.2013 Неактивен 3420
Azacitidine EU/1/08/488/001 Vidaza, powder for suspension for injection, 25 mg/ml, mg, Pack: 1 vial x 100 mg Celgene Europe B.V., Нидерландия Baxter Oncology GmbH, Kantstrasse 2, 33790 Halle/Westfalen, Германия; Celgene Europe Ltd, 1 Longwalk Road, Stockley Park, Uxbridge, UB11 1DB, Обединено кралство 591.97 118.39 710.36 4% 10 601.97 120.39 722.36 16% 25 626.97 125.39 752.36 Промяна на обстоятелствата НСР-16994/12.10.2018 НСР-7647/01.12.2015 (допуска предварително изпълнение); НСР-10740/27.10.2016 11.11.2016 02.11.2018 Активен 4121
Azacitidine EU/1/08/488/001 Vidaza, powder for suspension for injection, 25 mg/ml, mg, Pack: 1 vial x 100 mg Celgene Europe Limited, Обединено кралство, Обединено Кралство Baxter Oncology GmbH, Kantstrasse 2, 33790 Halle/Westfalen, Германия; Celgene Europe Ltd, 1 Longwalk Road, Stockley Park, Uxbridge, UB11 1DB, Обединено кралство 591.97 118.39 710.36 4% 10 601.97 120.39 722.36 16% 25 626.97 125.39 752.36 НСР-7647/01.12.2015 (допуска предварително изпълнение); НСР-10740/27.10.2016 11.11.2016 02.12.2016 Неактивен 4121
Azacitidine EU/1/08/488/001 Vidaza, powder for suspension for injection, 25 mg/ml, mg, Pack: 1 vial x 100 mg Celgene Europe Limited, Обединено кралство, Обединено Кралство Baxter Oncology GmbH, Kantstrasse 2, 33790 Halle/Westfalen, Германия; Celgene Europe Ltd, 1 Longwalk Road, Stockley Park, Uxbridge, UB11 1DB, Обединено кралство 622.62 124.52 747.14 4% 10 632.62 126.52 759.14 16% 25 657.62 131.52 789.14 НСР-7647/01.12.2015 (допуска предварително изпълнение) 02.12.2015 02.12.2015 Неактивен 4121
Didanosine II-0684/27.09.2007 VIDEX EC, Gastro resistant capsule, hard, 400, mg, Pack: 30 Bristol-Myers Squibb Kft, Унгария Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, F19250 Meymac, France 232.47 46.49 278.96 4% 9.3 241.77 48.35 290.12 16% 25 266.77 53.35 320.12 КЦРР-1000/23.07.2012; НСР-9745/14.07.2016 07.08.2012 02.08.2016 Заличен 1291
Didanosine II-0684/27.09.2007 VIDEX EC, Gastro resistant capsule, hard, 400, mg, Pack: 30 Bristol-Myers Squibb Kft, Унгария Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, F19250 Meymac, France 232.47 46.49 278.96 4% 9.3 241.77 48.35 290.12 16% 25 266.77 53.35 320.12 КЦРР-1000/23.07.2012 07.08.2012 07.08.2012 Неактивен 1291
Didanosine II-0681/27.09.2007 VIDEX EC, Gastro resistant capsule, hard, 250, mg, Pack: 30 Bristol-Myers Squibb Kft, Унгария Bristol-Myers Squibb, Champ “Lachaud”, La Goualle, F19250 Meymac, France 145.3 29.06 174.36 4% 5.81 151.11 30.22 181.33 16% 23.25 174.36 34.87 209.23 КЦРР-1000/23.07.2012; НСР-9746/14.07.2016 07.08.2012 02.08.2016 Заличен 1290
Showing 13776 to 13801 of 14685 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте